Company prices IPO at $1.17 a share in one of city’s largest floats this year By Kane Wu and Alec Macfarlane China Resources Pharmaceutical Group Ltd. has raised $1.8 billion in one of the biggest Hong Kong initial public offerings of the year. The company, controlled by a Chinese state-owned conglomerate, priced its IPO on […]
Mark Schlarbaum
“New China” Global Development
Telephone: (949) 570-8988